Funding opportunities
312 live opportunities from Grants.gov, NIH, NSF, and more.
Mathematics & Statistics× remove
- Harnessing antibody-driven bioconjugation to modulate immune functionNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $182,196activenih
- Fully recombinant, highly potent heptavalent botulinum antitoxin with ambient temperature stabilityNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $491,985activenih
- Next Generation pan-serotype,antitoxin for botulinum neurotoxin exposuresNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $531,688activenih
- The impact of tau on RNA and translation in progressive supranuclear palsyNational Institute on AgingPA-20-195 closes 5/31/2028up to $422,125activenih
- Prime editing therapeutics for LGMD2iEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-304 closes 5/31/2028up to $460,625activenih
- Improved Aminopyridine Analogs for Symptomatic Treatment of BotulismNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $480,448activenih
- Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparisonNational Cancer InstitutePAR-23-286 closes 5/31/2028up to $123,823activenih
- Proteasome Inhibitors as a Novel Drug-class for Treatment of GiardiasisNational Institute of Allergy and Infectious DiseasesPA-23-271 closes 5/31/2028up to $43,626activenih
- Quantitative Predictive Dosimetry for Curative Transarterial RadioembolizationNational Cancer InstitutePAR-25-135 closes 5/31/2028up to $161,460activenih
- Evaluating the Synergistic Therapeutic Effects of Retinoic Acid and the Proteasome Inhibitors in NeuroblastomaNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $467,968activenih
- Perfusion CT for liver radioembolizationNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $409,141activenih
- Development of Cdc14 inhibitors as novel antifungal agents against diverse fungal pathogensNational Institute of Allergy and Infectious DiseasesRFA-AI-24-065 closes 5/31/2028up to $229,127activenih
- New tricks from old genes: Investigating G-protein signaling as a mediator of colony morphology and aerobic glycolysis in Aspergillus fumigatusNational Institute of Allergy and Infectious DiseasesPA-25-422 closes 5/31/2028up to $50,114activenih
- Fragment-based targeting of EMT-mediated resistance in EGFR-mutant lung cancerNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $433,256activenih
- Using Artificial Intelligence to Estimate Personal Symptom Network for Cancer Survivorship CareNational Cancer InstitutePA-25-253 closes 5/31/2028up to $491,925activenih
- Effect of HIV Infection on Sickle Cell Disease Outcomes (EFHISA)John E. Fogarty International Center for Advanced Study in the Health SciencesPAR-23-191 closes 5/31/2028up to $156,179activenih
- Substances, Behaviors, and Outcomes of Adolescent Reporting to a Statewide Technology-Facilitated Reporting SystemNational Institute on Drug AbusePA-25-304 closes 5/31/2028up to $429,000activenih
- Environmental Modulation of Behavioral and Molecular Aging in Genetically Identical MiceNational Institute on AgingPA-24-194 closes 5/31/2028up to $136,350activenih
- Dynamic heterogeneity in the fatedecisions of early mammalian embryogenesisEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-422 closes 5/31/2028up to $34,114activenih
- Computational framework for aerosolization from vocal fold vibrationNational Institute on Deafness and Other Communication DisordersPA-25-422 closes 5/31/2028up to $46,115activenih
- Cyclic Antifungal Peptides for Drug-Resistant Invasive Fungal InfectionsNational Institute of Allergy and Infectious DiseasesRFA-AI-24-065 closes 5/31/2028up to $211,831activenih
- Increasing the throughput of variant classification with multiplexed prime editing and single cell long-read technologiesNational Human Genome Research InstitutePA-23-272 closes 5/31/2028up to $50,114activenih
- Non-Addictive Analgesic Discovery from Marine Microbial Natural ProductsNational Institute of Neurological Disorders and StrokeRFA-NS-25-023 closes 5/31/2028up to $1,009,623activenih
- Addressing Unmeasured Covariates in Source Cohorts with Transfer Learning for Survival OutcomesNational Cancer InstitutePAR-25-346 closes 5/31/2028up to $421,685activenih
- Uncovering spinal circuits recruited by descending facilitationNational Institute of Neurological Disorders and StrokeRFA-NS-22-022 closes 5/31/2028up to $129,330activenih